Ras mutations, found prevalent in about 20% of AML cases cause cell transformation through NADPH oxidase driven ROS, thereby promoting survival and growth factor-independent proliferation in human CD34+ cells [57]. This evidence concerns the gene FMO5 and acute myeloid leukemia.